Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling

A critical issue in the management of chronic kidney disease (CKD) is to prevent patients from the progression to end-stage kidney disease (ESKD), however, there is only limited number of biomarkers for the discrimination of the high-risk CKD patients. We aimed to identify the metabolites which poss...

Descripción completa

Detalles Bibliográficos
Autores principales: Kimura, Tomonori, Yasuda, Keiko, Yamamoto, Ryohei, Soga, Tomoyoshi, Rakugi, Hiromi, Hayashi, Terumasa, Isaka, Yoshitaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870629/
https://www.ncbi.nlm.nih.gov/pubmed/27188985
http://dx.doi.org/10.1038/srep26138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4870629/
https://www.ncbi.nlm.nih.gov/pubmed/27188985
http://dx.doi.org/10.1038/srep26138

Ejemplares similares